Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Case report

The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease

Authors: Tomohiro Terasaka, Haruhito A. Uchida, Ryoko Umebayashi, Keiko Tsukamoto, Keiko Tanaka, Masashi Kitagawa, Hitoshi Sugiyama, Hiroaki Tanioka, Jun Wada

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

A link between IgA nephropathy and Crohn’s disease has recently been reported. Other researchers hypothesize that intestine-derived IgA complexes deposit in glomerular mesangial cells, eliciting IgA nephropathy. Intestinal mucosal plasma cells mainly secrete IgA2. Nevertheless, IgA1 deposition is strongly implicated as being the primary cause of IgA nephropathy.

Case presentation

A 46-year-old Japanese man developed IgA nephropathy 29 years ago, following tonsillectomy. As a result, a normal urinalysis was obtained. The patient previously suffered Crohn’s disease followed by urinary occult blood and proteinuria six years ago. Exacerbation of IgA nephropathy was highly suspected. Therefore a renal biopsy was performed. A diagnosis of exacerbation of IgA nephropathy with mesangial cell proliferation and fibrotic cellular crescent was based upon the pathological findings. The patient exhibited a positive clinical course and eventually achieved a remission with immunosuppressive therapy including prednisolone treatment. Immunostaining for the detection of IgA subtypes was performed on both of his kidney and excised ileum. The results revealed IgA1 and IgA2 deposition by submucosal cells in intestine. Furthermore, IgA1 deposition of mesangial areas in the patient’s kidney, indicated an association of IgA1 with the exacerbation of IgA nephropathy.

Conclusion

This case represents the possibility that the intestine-derived IgA1 can be the origin of galactose-deficient IgA which is known to cause IgA nephropathy exacerbation.
Literature
1.
go back to reference Chiba M, et al. IgA1 & IgA2 distribution in the intestine. Gastroenterol Jpn. 1987;22:18–23.PubMed Chiba M, et al. IgA1 & IgA2 distribution in the intestine. Gastroenterol Jpn. 1987;22:18–23.PubMed
2.
go back to reference Mahoney S, et al. Systemic and mucosal antibodies to Klesiella in patients with ankylosing spondylitis and Crohn’s disease. Ann Rheum Dis. 1992;51:1296–300.CrossRef Mahoney S, et al. Systemic and mucosal antibodies to Klesiella in patients with ankylosing spondylitis and Crohn’s disease. Ann Rheum Dis. 1992;51:1296–300.CrossRef
4.
go back to reference Pipili C, et al. Is there aney association between IgA nephropathy, Crohn’s disease and Helicobacter pylori infection? Ren Fail. 2012;34:506–9.CrossRefPubMed Pipili C, et al. Is there aney association between IgA nephropathy, Crohn’s disease and Helicobacter pylori infection? Ren Fail. 2012;34:506–9.CrossRefPubMed
5.
go back to reference Rothfuss KS, et al. Extraintestinal manifestations and complications of inflammatory bowel diseases. World J Gastroenterol. 2006;12:4819–31.PubMedPubMedCentral Rothfuss KS, et al. Extraintestinal manifestations and complications of inflammatory bowel diseases. World J Gastroenterol. 2006;12:4819–31.PubMedPubMedCentral
6.
go back to reference Pardi DS, et al. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998;93:504–14.CrossRefPubMed Pardi DS, et al. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998;93:504–14.CrossRefPubMed
7.
go back to reference Waters AM, et al. Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn’s disease. Nat Clin Pract Nephrol. 2008;4:693–7.CrossRefPubMed Waters AM, et al. Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn’s disease. Nat Clin Pract Nephrol. 2008;4:693–7.CrossRefPubMed
8.
go back to reference Forshaw MJ, et al. IgA nephropathy in association with Crohn’s disease. Int J Color Dis. 2005;20:463–5.CrossRef Forshaw MJ, et al. IgA nephropathy in association with Crohn’s disease. Int J Color Dis. 2005;20:463–5.CrossRef
9.
go back to reference Xie Y, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003;63:1861–7.CrossRefPubMed Xie Y, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003;63:1861–7.CrossRefPubMed
10.
go back to reference Kawamura T, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant. 2014;29:1546–53.CrossRefPubMedPubMedCentral Kawamura T, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant. 2014;29:1546–53.CrossRefPubMedPubMedCentral
11.
go back to reference Ambruzs JM, et al. The Histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9:265–70.CrossRefPubMed Ambruzs JM, et al. The Histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9:265–70.CrossRefPubMed
12.
go back to reference Friedman BI, et al. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis. 1994;23:352–7.CrossRef Friedman BI, et al. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis. 1994;23:352–7.CrossRef
13.
go back to reference Toyoda H, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104:741–8.CrossRefPubMed Toyoda H, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104:741–8.CrossRefPubMed
14.
15.
go back to reference Davlin JC, et al. Increased intestinal permeability to (51Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediatr Scand. 1988;77:118–24.CrossRef Davlin JC, et al. Increased intestinal permeability to (51Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediatr Scand. 1988;77:118–24.CrossRef
16.
go back to reference Maté-Jimenez J, et al. Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol. 1996;8:1185–8.CrossRefPubMed Maté-Jimenez J, et al. Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol. 1996;8:1185–8.CrossRefPubMed
17.
go back to reference Filiopoulos V, et al. IgA nephropathy in association with Crohn’s disease: a case report and brief review of the literature. Ren Fail. 2010;32:523–7.CrossRefPubMed Filiopoulos V, et al. IgA nephropathy in association with Crohn’s disease: a case report and brief review of the literature. Ren Fail. 2010;32:523–7.CrossRefPubMed
18.
go back to reference Hiki Y, et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol. 1999;10:760–9.PubMed Hiki Y, et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol. 1999;10:760–9.PubMed
19.
go back to reference Tomana M, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73–81.CrossRefPubMedPubMedCentral Tomana M, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73–81.CrossRefPubMedPubMedCentral
Metadata
Title
The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease
Authors
Tomohiro Terasaka
Haruhito A. Uchida
Ryoko Umebayashi
Keiko Tsukamoto
Keiko Tanaka
Masashi Kitagawa
Hitoshi Sugiyama
Hiroaki Tanioka
Jun Wada
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0344-1

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue